Collective forecast

Synthesized
36%

Unlikely

Implants 100th patient36%
Does not implant 100th patient64%
Confidencelow· ~ news mixed

Single market source with low trading volume — no second market to cross-check against.

Based on 1 prediction market

90% range 2450% · moderate uncertainty (a thin, low-agreement signal)

The market's probability of 36.3% suggests a more optimistic view than the recent news indicates, which highlights both progress and significant challenges.

Forecast update

Updated 18d ago

First reading — check back to watch how this forecast moves.

Why this forecast

The market indicates a 36.3% chance that Neuralink will implant its 100th patient by 2027, reflecting uncertainty about the company's ability to scale its operations effectively. Recent news highlights Neuralink's progress with new procedures, but also suggests challenges in transitioning to mainstream technology.

Statistically pooled from 1 matched market (log-odds weighted by volume), 90% CI 24-50%.

Key development

Neuralink has successfully implanted its first Canadian patient, showcasing advancements in their technology.

Supporting signals

  • Neuralink's recent successful implantations demonstrate their technological advancements.
  • The new surgical procedure could facilitate faster patient onboarding.

Risk factors

  • Regulatory hurdles could delay further patient implants.
  • Competition from other companies may hinder Neuralink's market position.

This forecast assumes

  • Neuralink continues to receive regulatory approvals for its procedures.
  • The company maintains its current pace of technological development.

How this could unfold

Advancements in surgical technology
Increased funding for clinical trials
Growing acceptance of brain-computer interfaces
Implants 100th patient (36%)
Increased patient enrollment in trials
Potential for broader market adoption of brain-computer interfaces
Heightened competition in the tech space

Explore

Run the simulation

Replay this forecast 1,000 times, drawing from its own uncertainty band each time — watch how often implants 100th patient actually happens.

Build a scenario

Toggle the assumptions this forecast depends on, stack as many as you like, and run them together.

Neuralink continues to receive regulatory approvals for its procedures.
The company maintains its current pace of technological development.